Hester Biosciences Ltd
NSE:HESTERBIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hester Biosciences Ltd
NSE:HESTERBIO
|
IN |
|
T
|
Trulieve Cannabis Corp
CNSX:TRUL
|
US |
|
Mauna Kea Technologies SAS
PAR:MKEA
|
FR |
|
G
|
GrafTech International Ltd
F:G6G
|
US |
|
T
|
Tasco JSC
VN:HUT
|
VN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HESTERBIO's stock price target?
Not Available
HESTERBIO doesn't have any price targets made by Wall Street professionals.
What is Hester Biosciences Ltd's Operating Income forecast?
Projected CAGR
10%
For the last 13 years the
compound annual growth rate for
Hester Biosciences Ltd's operating income is
9%.
The projected
CAGR
for the next 5 years is
10%.